Nucleic acids encoding anti-CD154 antibodies
US11421037B2 · kind B2 · utility
0Cited by
35References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2020 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Feb 18, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antagonistic antibodies specifically binding CD154, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.